These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16838256)

  • 1. [Pediatric neuro-oncology].
    Navajas-Gutiérrez A
    Rev Neurol; 2006 Jul 16-31; 43(2):88-94. PubMed ID: 16838256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art chemotherapeutic management of pediatric brain tumors.
    Siegel MJ; Finlay JL; Zacharoulis S
    Expert Rev Neurother; 2006 May; 6(5):765-79. PubMed ID: 16734524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of pediatric brain tumors.
    Rutka JT; Kuo JS; Carter M; Ray A; Ueda S; Mainprize TG
    Expert Rev Neurother; 2004 Sep; 4(5):879-93. PubMed ID: 15853514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tumors in children: a review.
    Lacayo A; Farmer PM
    Ann Clin Lab Sci; 1991; 21(1):26-35. PubMed ID: 2012378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study group on brain tumors in childhood. Introduction, establishment and aims].
    Kühl J
    Klin Padiatr; 1987; 199(3):196-9. PubMed ID: 3626420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development in chemotherapy of paediatric brain tumours.
    Grill J; Bhangoo R
    Curr Opin Oncol; 2007 Nov; 19(6):612-5. PubMed ID: 17906461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
    Papolos D; Mattis S; Golshan S; Molay F
    J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of chemotherapy in brain tumors in children--possibilities and perspectives].
    Barjaktarević Z; Jeremić B; Sobić V
    Srp Arh Celok Lek; 1989; 117(11-12):837-49. PubMed ID: 2491000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying pediatric neuro-oncology risk factors: development of the neurological predictor scale.
    Micklewright JL; King TZ; Morris RD; Krawiecki N
    J Child Neurol; 2008 Apr; 23(4):455-8. PubMed ID: 18182641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OMICS and brain tumour biomarkers.
    Petrik V; Loosemore A; Howe FA; Bell BA; Papadopoulos MC
    Br J Neurosurg; 2006 Oct; 20(5):275-80. PubMed ID: 17129872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
    Brandes AA; Franceschi E; Tosoni A; Reni M; Gatta G; Vecht C; Kortmann RD
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):165-79. PubMed ID: 19303318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer.
    Riva M; Landonio G; Arena O; Citterio A; Galli C; Ferrante E; Brioschi A; Collice M; Gambacorta M; Scialfa G; Defanti CA; Siena S
    Forum (Genova); 2001; 11(1):4-26. PubMed ID: 11734861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes in brain tumors: prognostic and therapeutic impact.
    Sanson M; Laigle-Donadey F; Benouaich-Amiel A
    Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bilateral thalamic tumours. Three case reports and a review of the literature].
    Gelabert-González M; Seramito-García R; Bandín-Diéguez J; Allut AG
    Rev Neurol; 2007 Nov 16-30; 45(10):599-603. PubMed ID: 18008265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the management of pediatric central nervous system tumors.
    Abdullah S; Qaddoumi I; Bouffet E
    Ann N Y Acad Sci; 2008 Sep; 1138():22-31. PubMed ID: 18837879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment approaches for infants with malignant central nervous system tumors.
    Lafay-Cousin L; Strother D
    Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central nervous system tumours in childhood: their clinical pathological aspects].
    Ortega Aznar A; Romero Vidal FJ
    Rev Neurol; 2004 Mar 16-31; 38(6):554-64. PubMed ID: 15054721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imidazoline I(2) receptors as a possible marker for malignancy in human glial cell tumours].
    Callado LF; Garibi JM; Meana JJ
    Rev Neurol; 2006 Oct 16-31; 43(8):476-80. PubMed ID: 17033981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives in diagnosis and management of malignant gliomas].
    Psimaras D; Delattre JY
    Cancer Radiother; 2008 Nov; 12(6-7):695-700. PubMed ID: 18829366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.